Nasdaq:US$18.56 (-0.72) | HKEX:HK$29.35 (-0.85) | AIM:£2.90 (-0.15)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 16 Apr 2023

AACR 2023: Preclinical characteristic of HMPL-306, a CNS-penetrable dual inhibitor of mutant IDH1 and IDH2